AndersenKG, RambautA, LipkinWI. The proximal origin of SARS-CoV-2. Nat Med2020; 26: 450–2.
3.
JonesKE, PatelNG, LevyMA. Global trends in emerging infectious diseases. Nature2008; 451: 990–3.
4.
SemenzaJC, RocklövJ, PenttinenP. Observed and projected drivers of emerging infectious diseases in Europe. Ann N Y Acad Sci2016; 1382:73–83.
5.
LederK, TorresiJ, BrownsteinJ. Geosentinel surveillance of illness in returned travelers. Ann Intern Med2013; 158: 456–68.
6.
ZaguryI, Schwartsztein. Covid-19 – A reminder to reason, N Engl J Med doi: 10.1056/NEJMp2009405. [Epub ahead of print 28/04/20].
7.
Toniati P., Piva S., Cattalini M et al. Tocilizumab for the treatment of severe covid-19 pneumonia with hyperinflammatory syndrome and acute respiratory failure: a single center study of 100 patients in Brescia, Italy. Autoimmun Rev 2020 doi: 10.1016/j.autrev.2020.102568. [Epub ahead of print 03/05/20].
8.
Grein J, Ohmagari N, Shin D et al. Compassionate Use of Remdesivir for Patients with Severe Covid-19. N Engl J Med. doi: 10.1056/NEJMoa2007016. [Epub ahead of print 10/04/20].